Indeed, overexpression of EZH2 was shown to correlate with breast cancer aggressiveness and poor patient prognosis [2,4] and the PRC2 complex is up-regulated in breast cancer lymph node metastasis compared to primary tumors [17]. This evidence concerns the gene EZH2 and breast cancer.